search
Back to results

Concentrations of Remifentanil for Extubation (REMEX)

Primary Purpose

Cough

Status
Completed
Phase
Phase 4
Locations
Colombia
Study Type
Interventional
Intervention
Extubation U
Extubation T
Sponsored by
Seganest
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cough focused on measuring Extubation, Cough, Target Controlled Anesthesia (TACAN)

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All patients aged 18-70 years
  • Risk Scale American Society of Anaesthesiologists physical status classification (ASA) I and II
  • Undergoing elective ear surgery

Exclusion Criteria:

  • Patients who are contraindicated remifentanil
  • Patients undergoing emergency surgery
  • Pulmonary Pathology (ASTHMA - COPD)
  • Index of body mass greater than 35
  • Background of respiratory failure three weeks prior to the procedure
  • Smokers

Sites / Locations

  • Instituto Para Niños Ciegos y Sordos del Valle del Cauca

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Extubation U

Extubation T

Arm Description

Remifentanil concentration between 2 - 3 ng/ml.

Remifentanil concentration between 3 - 4 ng/ml

Outcomes

Primary Outcome Measures

Cough
Number of episodes and duration of cough that occur when the patient responds to verbal stimulus and extubated. Cough Scale Grade 0 = No cough Grade 1 = Mild (only episode of cough) Grade 2 = Moderate (more than 1episode of cough during less than 5 seconds) Grade 3 = Severe (More than one episode of cough that lasted more than 5 seconds or purposeless movements of the extremities).

Secondary Outcome Measures

Wake time.
When vaporizer where closed until the patient responds to the verbal stimulus and is extubated. Defined as the time taken to open eyes after having turned off the halogenated inhalation anesthetics.
Ramsay scale at the time of extubation
Ramsay scale: score objective system for measuring drug-induced sedation Score 1: Anxious or restless or both Score 2: Cooperative, orientated and tranquil Score 3: Responding to commands Score 4: Brisk response to stimulus Score 5: Sluggish response to stimulus Score 6: No response to stimulus

Full Information

First Posted
August 27, 2013
Last Updated
March 16, 2016
Sponsor
Seganest
Collaborators
Instituto Para Ninos Ciegos y Sordos del Valle del Cauca
search

1. Study Identification

Unique Protocol Identification Number
NCT02711904
Brief Title
Concentrations of Remifentanil for Extubation
Acronym
REMEX
Official Title
Effect of Two Plasma Concentrations of Remifentanil Through Target Controlled Anesthesia on Frequency and Intensity of Coughing During Extubation: Randomized Controlled Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2016
Overall Recruitment Status
Completed
Study Start Date
January 2011 (undefined)
Primary Completion Date
January 2011 (Actual)
Study Completion Date
July 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seganest
Collaborators
Instituto Para Ninos Ciegos y Sordos del Valle del Cauca

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Condition of the State: (terminated, recruiting, etc.) Terminated Study Design: Main Objective: Compare the frequency and intensity of coughing at the time of extubation with two infusions of remifentanil that predict a plasma concentration (PC) of 3 - 4 and 2 - 3 ng/ml, through the technique of target controlled anesthesia
Detailed Description
Phase of the study: Phase IV Intervention: Drug: U Extubation Other Names: Concentration 2 - 3 ng/ml Dose of remifentanil according to the randomization: Letter U between 2 - 3 ng/ml. The infusions that were used to reach the (PC) target were: Group U = 2 - 3 ng/ml. 20 years old - 6.0 mcg/Kg/h, 30 years old - 5.7 mcg/Kg/h, 40 years old - 5.3 mcg/kg/h, 50 years old - 5.0 mcg/kg/h, 60 years old - 4.6 mcg/kg/h, 70 years old - 4.3 mcg/kg/h, 80 years old - 4.0 mcg kg/h. Drug: Extubation T Other Names: Concentration 3 - 4 ng/ml Dose of infusion of remifentanil to reach a (PC) 3 - 4 ng/ml, in the following manner: The assistant placed the infusion balloon in such a way that it could not be seen by the treating anesthesiologist, he proceeded to open the corresponding wrapping according to the consecutive which corresponds to the patient. The remifentanil dose was adjusted according to the randomization: Group T = 3 - 4 ng/ml. 20 years old - 9.0 mcg/Kg/h, 30 years old - 8.5 mcg/Kg/h, 40 years old - 8.0 mcg/kg/h, 50 years old - 7.5 mcg/kg/h, 60 years old - 7.0 mcg/kg/h, 70 years old - 6.5 mcg/kg/h, 80 years old - 6.0 mcg kg/h. Number of arms: 2 Masking: The patient had masking with regards to the anesthetic procedure from the unfamiliarity per se of the same and by agents used in this that induced anxiolysis and hypnosis. To guarantee the masking to the viewer, which was the treating anesthesiologist, a nurse was trained in the adjustment of the infusion balloon. Ten minutes before concluding the procedure and by request of the anesthesiologist, the nurse proceeded to locate balloon in such a way that the infusion could not be seen by the anesthesiologist, then opened the envelope and adjusted the infusion according to the randomization (U) o (T). The evaluation of the cough, its intensity and the Ramsay were under the care of the anesthesiologist, who was unaware of the awakening infusion. Allocation: Two were allocated for the use: Concentration of remifentanil of 2 - 3 ng/ml (group U) and concentration of remifentanil of 3 - 4 ng/ml (group T). Recruitment: A patient was recruited between the period of January 2011 and July 2012.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cough
Keywords
Extubation, Cough, Target Controlled Anesthesia (TACAN)

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
110 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Extubation U
Arm Type
Active Comparator
Arm Description
Remifentanil concentration between 2 - 3 ng/ml.
Arm Title
Extubation T
Arm Type
Experimental
Arm Description
Remifentanil concentration between 3 - 4 ng/ml
Intervention Type
Drug
Intervention Name(s)
Extubation U
Other Intervention Name(s)
Ultiva
Intervention Description
Dose of remifentanil according to the randomization; the infusions that were used to reach the PC target were: 20 years old - 6.0 mcg/Kg/h 30 years old - 5.7 mcg/Kg/h 40 years old - 5.3 mcg/kg/h 50 years old - 5.0 mcg/kg/h 60 years old - 4.6 mcg/kg/h 70 years old - 4.3 mcg/kg/h 80 years old - 4.0 mcg kg/h.
Intervention Type
Drug
Intervention Name(s)
Extubation T
Other Intervention Name(s)
Ultiva
Intervention Description
Dose of infusion of remifentanil to reach a PC 3 - 4 ng/ml, in the following manner: The assistant placed the infusion balloon in such a way that it could not be seen by the treating anesthesiologist, he proceeded to open the corresponding wrapping according to the consecutive which corresponds to the patient. The remifentanil dose was adjusted according to the randomization: 20 years old - 9.0 mcg/Kg/h 30 years old - 8.5 mcg/Kg/h 40 years old - 8.0 mcg/kg/h 50 years old - 7.5 mcg/kg/h 60 years old - 7.0 mcg/kg/h 70 years old - 6.5 mcg/kg/h 80 years old - 6.0 mcg kg/h.
Primary Outcome Measure Information:
Title
Cough
Description
Number of episodes and duration of cough that occur when the patient responds to verbal stimulus and extubated. Cough Scale Grade 0 = No cough Grade 1 = Mild (only episode of cough) Grade 2 = Moderate (more than 1episode of cough during less than 5 seconds) Grade 3 = Severe (More than one episode of cough that lasted more than 5 seconds or purposeless movements of the extremities).
Time Frame
It is evaluated by the scale of cough over a two hour period after surgery: is assessed at 5 minutes turned off the halogenated inhalation anesthetics, thereafter every minute until the patient responds to verbal stimulus and can be extubated
Secondary Outcome Measure Information:
Title
Wake time.
Description
When vaporizer where closed until the patient responds to the verbal stimulus and is extubated. Defined as the time taken to open eyes after having turned off the halogenated inhalation anesthetics.
Time Frame
During two hours after surgery, five minutes after turning off halogenated inhaled anesthetics, then every minute until the patient opens his eyes and is extubated.
Title
Ramsay scale at the time of extubation
Description
Ramsay scale: score objective system for measuring drug-induced sedation Score 1: Anxious or restless or both Score 2: Cooperative, orientated and tranquil Score 3: Responding to commands Score 4: Brisk response to stimulus Score 5: Sluggish response to stimulus Score 6: No response to stimulus
Time Frame
During two hours after surgery, the estimated time period during which the event was assessed five (5) minutes after every minute, until answered

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All patients aged 18-70 years Risk Scale American Society of Anaesthesiologists physical status classification (ASA) I and II Undergoing elective ear surgery Exclusion Criteria: Patients who are contraindicated remifentanil Patients undergoing emergency surgery Pulmonary Pathology (ASTHMA - COPD) Index of body mass greater than 35 Background of respiratory failure three weeks prior to the procedure Smokers
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
LUIS A TAFUR, MD
Organizational Affiliation
Seganest
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Eduardo Lema, MD
Organizational Affiliation
Seganest
Official's Role
Study Director
Facility Information:
Facility Name
Instituto Para Niños Ciegos y Sordos del Valle del Cauca
City
Santiago de Cali
State/Province
Valle del Cauca
ZIP/Postal Code
288 00
Country
Colombia

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
The individual data of the participants (IPD) were only available to the ethics committee of the institution.
Citations:
PubMed Identifier
8024135
Citation
Neelakanta G, Miller J. Minimum alveolar concentration of isoflurane for tracheal extubation in deeply anesthetized children. Anesthesiology. 1994 Apr;80(4):811-3. doi: 10.1097/00000542-199404000-00013.
Results Reference
background
PubMed Identifier
16095449
Citation
Guler G, Akin A, Tosun Z, Eskitascoglu E, Mizrak A, Boyaci A. Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anaesthesiol Scand. 2005 Sep;49(8):1088-91. doi: 10.1111/j.1399-6576.2005.00780.x.
Results Reference
background
PubMed Identifier
16450594
Citation
Saghaei M, Reisinejad A, Soltani H. Prophylactic versus therapeutic administration of intravenous lidocaine for suppression of post-extubation cough following cataract surgery: a randomized double blind placebo controlled clinical trial. Acta Anaesthesiol Taiwan. 2005 Dec;43(4):205-9.
Results Reference
background
PubMed Identifier
15385385
Citation
Minogue SC, Ralph J, Lampa MJ. Laryngotracheal topicalization with lidocaine before intubation decreases the incidence of coughing on emergence from general anesthesia. Anesth Analg. 2004 Oct;99(4):1253-1257. doi: 10.1213/01.ANE.0000132779.27085.52.
Results Reference
background
PubMed Identifier
10866913
Citation
Fagan C, Frizelle HP, Laffey J, Hannon V, Carey M. The effects of intracuff lidocaine on endotracheal-tube-induced emergence phenomena after general anesthesia. Anesth Analg. 2000 Jul;91(1):201-5. doi: 10.1097/00000539-200007000-00038.
Results Reference
background
PubMed Identifier
9637637
Citation
Tagaito Y, Isono S, Nishino T. Upper airway reflexes during a combination of propofol and fentanyl anesthesia. Anesthesiology. 1998 Jun;88(6):1459-66. doi: 10.1097/00000542-199806000-00007.
Results Reference
background
PubMed Identifier
7725888
Citation
Nishina K, Mikawa K, Maekawa N, Obara H. Fentanyl attenuates cardiovascular responses to tracheal extubation. Acta Anaesthesiol Scand. 1995 Jan;39(1):85-9. doi: 10.1111/j.1399-6576.1995.tb05597.x.
Results Reference
background
PubMed Identifier
7598918
Citation
Mendel P, Fredman B, White PF. Alfentanil suppresses coughing and agitation during emergence from isoflurane anesthesia. J Clin Anesth. 1995 Mar;7(2):114-8. doi: 10.1016/0952-8180(94)00024-x.
Results Reference
background
PubMed Identifier
11240151
Citation
Sant'Ambrogio G, Widdicombe J. Reflexes from airway rapidly adapting receptors. Respir Physiol. 2001 Mar;125(1-2):33-45. doi: 10.1016/s0034-5687(00)00203-6.
Results Reference
background
PubMed Identifier
20422846
Citation
Lema FE, Tafur LA, Giraldo C, Delgado MA. [Incidence of cough after desflurane and sevoflurane administration through a laryngeal mask: a controlled clinical trial]. Rev Esp Anestesiol Reanim. 2010 Mar;57(3):141-6. doi: 10.1016/s0034-9356(10)70188-2. Spanish.
Results Reference
background
PubMed Identifier
4835444
Citation
Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974 Jun 22;2(5920):656-9. doi: 10.1136/bmj.2.5920.656.
Results Reference
background
PubMed Identifier
10073732
Citation
Grahame-Smith DG. How will knowledge of the human genome affect drug therapy? Br J Clin Pharmacol. 1999 Jan;47(1):7-10. doi: 10.1046/j.1365-2125.1999.00909.x. No abstract available.
Results Reference
background
PubMed Identifier
15536889
Citation
Van Poucke GE, Bravo LJ, Shafer SL. Target controlled infusions: targeting the effect site while limiting peak plasma concentration. IEEE Trans Biomed Eng. 2004 Nov;51(11):1869-75. doi: 10.1109/TBME.2004.827935.
Results Reference
background
Citation
Tafur LA, Gómez JM, Parra LE. Validación de nomogramas de remifentanil y propofol para la administración de anestesia total endovenosa. Rev. Col. Anest. 2009; 37:21-8.
Results Reference
background
PubMed Identifier
12883407
Citation
Mertens MJ, Olofsen E, Engbers FH, Burm AG, Bovill JG, Vuyk J. Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil-propofol interactions. Anesthesiology. 2003 Aug;99(2):347-59. doi: 10.1097/00000542-200308000-00016.
Results Reference
background
PubMed Identifier
11574362
Citation
Eger EI 2nd. Age, minimum alveolar anesthetic concentration, and minimum alveolar anesthetic concentration-awake. Anesth Analg. 2001 Oct;93(4):947-53. doi: 10.1097/00000539-200110000-00029.
Results Reference
background
PubMed Identifier
19168857
Citation
Matsuura T, Oda Y, Tanaka K, Mori T, Nishikawa K, Asada A. Advance of age decreases the minimum alveolar concentrations of isoflurane and sevoflurane for maintaining bispectral index below 50. Br J Anaesth. 2009 Mar;102(3):331-5. doi: 10.1093/bja/aen382. Epub 2009 Jan 24.
Results Reference
background
PubMed Identifier
14739797
Citation
Albertin A, Casati A, Bergonzi P, Fano G, Torri G. Effects of two target-controlled concentrations (1 and 3 ng/ml) of remifentanil on MAC(BAR) of sevoflurane. Anesthesiology. 2004 Feb;100(2):255-9. doi: 10.1097/00000542-200402000-00012.
Results Reference
background
PubMed Identifier
11873028
Citation
Olofsen E, Sleigh JW, Dahan A. The influence of remifentanil on the dynamic relationship between sevoflurane and surrogate anesthetic effect measures derived from the EEG. Anesthesiology. 2002 Mar;96(3):555-64. doi: 10.1097/00000542-200203000-00009.
Results Reference
background
PubMed Identifier
16871060
Citation
Manyam SC, Gupta DK, Johnson KB, White JL, Pace NL, Westenskow DR, Egan TD. Opioid-volatile anesthetic synergy: a response surface model with remifentanil and sevoflurane as prototypes. Anesthesiology. 2006 Aug;105(2):267-78. doi: 10.1097/00000542-200608000-00009.
Results Reference
background
Citation
Dennis R. Cómo estimar el tamaño de la muestra en investigación con humanos. Acta Méd Colom. 1989;14: 92-99.
Results Reference
background
Citation
Dobson AJ. Calculating simple size. Transactions of the Menzie Foundation. 1984; 7:75-79.
Results Reference
background
PubMed Identifier
15220181
Citation
Lerou JG. Nomogram to estimate age-related MAC. Br J Anaesth. 2004 Aug;93(2):288-91. doi: 10.1093/bja/aeh186. Epub 2004 Jun 25.
Results Reference
background
Citation
Coleridge HM, Coleridge JCC. Reflexes evoked from the tracheobronchial tree and lungs. In: Handbook of Physiology, Section 3: the Respiratory System, Vol II: Control of Breathing, Part I (Cherniack NS, Widdicombe JG, eds). Washington, DC:American Physiological Society, 1986;395-429.
Results Reference
background
Citation
Widdicombe JG. Vagal reflexes in the airways. In: Neural Regulation of the Airways in Health and Disease (Kaliner M, Barnes PJ, eds). New York:Marcel Dekker, 1988;187-202.
Results Reference
background
PubMed Identifier
21738845
Citation
Lee DH, Park SJ. Effects of 10% lidocaine spray on arterial pressure increase due to suspension laryngoscopy and cough during extubation. Korean J Anesthesiol. 2011 Jun;60(6):422-7. doi: 10.4097/kjae.2011.60.6.422. Epub 2011 Jun 17.
Results Reference
background
PubMed Identifier
16428692
Citation
Irwin RS. Complications of cough: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1 Suppl):54S-58S. doi: 10.1378/chest.129.1_suppl.54S.
Results Reference
background
PubMed Identifier
4451611
Citation
Leech P, Barker J, Fitch W. Proceedings: Changes in intracranial pressure and systemic arterial pressure during the termination of anaesthesia. Br J Anaesth. 1974 Apr;46(4):315-6. doi: 10.1093/bja/46.4.315-a. No abstract available.
Results Reference
background
PubMed Identifier
19411668
Citation
Lee B, Lee JR, Na S. Targeting smooth emergence: the effect site concentration of remifentanil for preventing cough during emergence during propofol-remifentanil anaesthesia for thyroid surgery. Br J Anaesth. 2009 Jun;102(6):775-8. doi: 10.1093/bja/aep090. Epub 2009 May 2.
Results Reference
background
PubMed Identifier
17660457
Citation
Hohlrieder M, Tiefenthaler W, Klaus H, Gabl M, Kavakebi P, Keller C, Benzer A. Effect of total intravenous anaesthesia and balanced anaesthesia on the frequency of coughing during emergence from the anaesthesia. Br J Anaesth. 2007 Oct;99(4):587-91. doi: 10.1093/bja/aem203. Epub 2007 Jul 27.
Results Reference
background
PubMed Identifier
10673886
Citation
Shajar MA, Thompson JP, Hall AP, Leslie NA, Fox AJ. Effect of a remifentanil bolus dose on the cardiovascular response to emergence from anaesthesia and tracheal extubation. Br J Anaesth. 1999 Oct;83(4):654-6. doi: 10.1093/bja/83.4.654.
Results Reference
background
PubMed Identifier
11575408
Citation
Wilhelm W, Schlaich N, Harrer J, Kleinschmidt S, Muller M, Larsen R. Recovery and neurological examination after remifentanil-desflurane or fentanyl-desflurane anaesthesia for carotid artery surgery. Br J Anaesth. 2001 Jan;86(1):44-9. doi: 10.1093/bja/86.1.44.
Results Reference
background
PubMed Identifier
20645945
Citation
Jun NH, Lee JW, Song JW, Koh JC, Park WS, Shim YH. Optimal effect-site concentration of remifentanil for preventing cough during emergence from sevoflurane-remifentanil anaesthesia. Anaesthesia. 2010 Sep;65(9):930-5. doi: 10.1111/j.1365-2044.2010.06450.x.
Results Reference
background

Learn more about this trial

Concentrations of Remifentanil for Extubation

We'll reach out to this number within 24 hrs